H.Con.Res. 42 · 117th Congress · House

Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Active· Referred to the Subcommittee on Health.
Introduced
Jul 21, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.

Action Timeline

4
  1. JUL 22, 2021•Committee

    Referred to the Subcommittee on Health.

  2. JUL 21, 2021•IntroReferral

    Introduced in House

  3. JUL 21, 2021•IntroReferral

    Introduced in House

  4. JUL 21, 2021•IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Jul 22, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Jul 21, 2021

Active